Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Other neoplasm 1

Conditions

Malignant Neoplasms of Digestive Organs 1

Interventions

Gemcitabine 2Aminolevulinic Acid 2toripalimab 1tirbanibulin 1ruxolitinib 1potassium oxonate 1penpulimab 1human papillomavirus vaccine, L1 type 16, 18 1gimeracil 1apatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Toremifene 1Tegafur 1Robotic Surgical Procedures 1Rifampin 1RAD140 1Pregnancy Tests 1Pemetrexed 1ON 01910 1Nivolumab 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hysterectomy 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Excipients 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × potassium oxonate × Other neoplasm × Clear all
NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡